Clinical trial · Interventional
Optical Coherence Tomography (OCT) Based Screening of Esophagus and Gastroesophageal Junction
Optical Coherence Tomography Based Screening and Surveillance of Esophagus and Gastroesophageal Junction
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The specific aim of this study is to determine the accuracy of Optical Coherence Tomography (OCT) imaging for screening and diagnosis of the distal esophagus in patients undergoing a clinical esophagogastroduodenoscopy (EGD) procedure. The accuracy of results obtained using the developed OCT imaging probe will be determined and compared with those obtained through the traditional standard of care endoscopic biopsy .
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Barrett's Esophagus | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Optical Frequency Domain Imaging (OFDI) | Device | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- Optical Frequency Domain imaging System
- description
- Optical Frequency Domain Imaging (OFDI) balloon based imaging
- interventionNames
- Device: Optical Frequency Domain Imaging (OFDI)
Primary outcomes (1)
- measure
- Number of Subjects in Which the Entire Distal Esophagus Can be Visualized Using the Balloon Based Optical Coherence Tomography Screening
- timeFrame
- Images will be acquired during the OFDI imaging session which should take an average of 5 minutes
- description
- Collected entire distal esophagus OFDI Images analyzed and compared to the images obtained during standard of care surveillance endoscopy.
Eligibility
Eligibility (as posted)
- Sex
- All
Show eligibility criteria text
Inclusion Criteria: * over the age of 18, * capable of giving informed consent, * are undergoing elective EGD, and * if female are willing to take a pregnancy test Exclusion Criteria: * patients on oral anticoagulation medications, * with a history of hemostasis disorders and * patients that are pregnant
References
Publications (0)
Data not yet available